Authorized Representative (EU)
Legal entity established in the EU that represents a non-EU manufacturer for MDR/IVDR purposes.
Definition
The Authorized Representative is mandated by a written contract, registered in EUDAMED, and shares specific liabilities with the manufacturer. They hold technical documentation, interface with competent authorities, and handle vigilance reports.What this means in practice
Choosing a competent EC REP with strong notified-body and competent-authority relationships is a strategic - not just administrative - decision.Examples
- A US-based MedTech manufacturer appoints a German Authorized Representative to place their Class IIa surgical device on the EU market.
- An EU competent authority contacts the Authorized Representative of a Japanese medical device company to request clarification on a vigilance report.
- A manufacturer updates their technical documentation in response to a notified body audit, and the Authorized Representative ensures they have the latest version.
- •Misunderstanding the Authorized Representative as a mere postal address, rather than a key regulatory actor with legally defined responsibilities.
- •Failing to provide the Authorized Representative with full access to technical documentation, hindering their ability to perform required checks.
- •Assuming the Authorized Representative bears sole liability, whereas liability is shared with the manufacturer for non-compliance.
- •Not establishing a clear, written mandate with defined responsibilities, as required by EU MDR Article 11(3).
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsRegulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU.
Regulation (EU) 2017/745 governing medical devices in the European Union.
UK-based equivalent of the EU Authorized Representative required for non-UK manufacturers placing devices on the GB market.
More in Regulatory
· Same categoryFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Primary references
3 sources- 1
MDR Article 11VerifiedEUR-Lexeur-lex.europa.eu
- 2
IMDRF DocumentsVerifiedIMDRFimdrf.org
- 3
RAPS Regulatory FocusVerifiedRAPSraps.org
Inline markers like [1] jump to the matching reference above.